Testing and evaluation of anti-inflammatory compounds in lung models using colony forming units (CFU) assessment, survival and inflammatory marker assessment.
Closed Special Notice Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- W81XWH19R0010
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Virginia, United States
Notice details come from SAM.gov. Updated .
Notice text
The U.S. Army Medical Research Acquisition Activity (USAMRAA) intends to award a single sole source contract to the University of Virginia (UVA) for testing and evaluation of anti-inflammatory compounds in lung models using colony forming units (CFU) assessment, survival and inflammatory marker assessment. This new requirement is to acquire specialized anti-inflammatory compounds that are proprietary to UVA, in support of the Walter Reed Army Institute of Research (WRAIR).
This is a notice of intent to issue an award on the basis of other than full and open competition in accordance with the Federal Acquisition Regulation (FAR) 6.302-1 only one responsible source and no other supplies of services will satisfy agency requirements.
.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Redacted J&A - W81XWH19C0074 | Award Notice | |
| This notice | Special Notice | |
| Anti-inflammatory Compound Assessment | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity